Joint venture agreement for PPE procurement and distribution
Company: CleanSpark
What the later record shows
Not a promise: a reported event · happened April 6, 2020
The claim reports a joint venture agreement that had already been signed. A later 10-Q dates the signing to April 6, 2020.
“On April 6, 2020, the Company entered into a joint venture agreement with third party partners to procure, distribute, and supply Personal Protective Equipment (PPE)”
2020-08-03 · CleanSpark 10-Q filed 2020-08-04 View cached copy (2026-09-13)Live source ↗
Checked October 9, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
Entered into joint venture agreement with international partners to procure, distribute and supply N-95 masks, KN-95 masks, gowns, gloves and other PPE to hospitals and frontline medical personnel during COVID-19 outbreak, effective until December 31, 2020
Source (primary)
CleanSpark 8-K filed 2020-04-09 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “entered into a joint venture agreement (the "Agreement") with international partners to procure, distribute and supply significant quantities of N-95 masks, KN-95 masks, gowns, gloves and other Personal Protective Equipment (PPE) to be supplied to hospitals and frontline medical personnel who are in dire need while fighting the COVID-19 outbreak in the United States (the "Joint Venture"). The Agreement is effective until December 31, 2020 (the "Term")”
How we checked this
Checked on October 11, 2026. The cited source supports every part of this claim.
The 8-K states that CleanSpark entered a joint venture with international partners to supply PPE to hospitals and frontline medical workers during COVID-19. It also states the agreement runs until December 31, 2020 unless extended.
Confirmed in the source:
- CleanSpark entered into a joint venture agreement with international partners (April 6, 2020)
- The joint venture's purpose is to procure, distribute and supply N-95 masks, KN-95 masks, gowns, gloves and other PPE
- The PPE is to be supplied to hospitals and frontline medical personnel fighting the COVID-19 outbreak in the United States
- The agreement is effective until December 31, 2020
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/827876/000166357720000086/clsk8k.htm) in full (7,964 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms CleanSpark 8-K filed 2020-04-09
Quote: “entered into a joint venture agreement (the "Agreement") with international partners to procure, distribute and supply significant quantities of N-95 masks, KN-95 masks, gowns, gloves and other Personal Protective Equipment (PPE) to be supplied to hospitals and frontline medical personnel who are in dire need while fighting the COVID-19 outbreak in the United States (the "Joint Venture"). The Agreement is effective until December 31, 2020 (the "Term")”
